Aegle Therapeutics

Developing extracellular vesicle therapies for debilitating rare diseases and dermatological disorders

placeMiami, Florida, United States calendar_todayFounded 2013 groups4 employees language aegletherapeutics.com

Social engagement

Social engagement: 1.4K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include New World Angels.

Investor typeCountShare
Venture capital667%
Private equity111%
Angel & family office111%
Accelerator & incubator111%

Recent activity

10 Oct 2025
Event
BioFuture2025
7 Oct 2025
Event
BioFuture2025
15 Jul 2025
Leadership hire
Chairman of the Aegle Therapeutics Board of Directors
Coming soon